The "Taxi of Tomorrow" has arrived in New York City. On Tuesday night, officials unveiled the Nissan-designed cab that, over the next 10 years, will gradually replace the country's largest taxi fleet. It's the first New York taxi to be designed for the job since the city's iconic Checker cab.
For Nissan's designers, the process of putting the new cab together involved months of riding in taxis and talking to cab owners, drivers and passengers about what they did and didn't like.
The brains of people who grow up speaking two languages are wired differently, and those differences protect them from dementia as they age.
That's the news from two studies out this month from a scientist in Canada who has spent decades trying to figure out whether being bilingual is bad or good. "I've been doing this for 25 years," Ellen Bialystok, a distinguished research professor of psychology at York University in Toronto, tells Shots. "Suddenly people are interested. I figure it's because everybody's scared about dementia."
Former Child Star Fatigue. Many of us have suffered it, given the drug problems, the meltdowns, the awful nude photos.
But then there's Fred Savage, who starred in the ABC show The Wonder Years from 1988 through 1993. Now he's a successful, slightly offbeat 35-five-year-old television producer and director. He works on wicked, slightly warped comedies including Party Down, It's Always Sunny In Philadelphia and as of today, Best Friends Forever. His first network sitcom premieres tonight on NBC.
Locavores, a word with you. Local food may be gaining traction in all kinds of ways, but a report out today from the Institute of Medicine serves as a stark reminder of just how globalized our food system truly is.
"Political fundraiser" has a fancy ring to it — tuxedos, famous singers, billionaires. In fact, most political fundraisers aren't that glamorous.
Think instead of a dozen lobbyists eating breakfast with a Congressman in a side room at some DC restaurant. Off in a corner, someone who works for the Congressman is holding the checks the lobbyists brought to get in the door.
Another batch of phony cancer drugs has made its way into the U.S., the Food and Drug Administration says.
U.S.-based medical practices purchased vials of counterfeit medicine labeled as Altuzan from a foreign supplier, FDA spokesperson Shelly Burgess tells Shots. She said the agency doesn't have any reports of patients having received the counterfeit drugs.
Altuzan is the Turkish brand name for Avastin, the FDA-approved blockbuster cancer drug from Swiss drugmaker Roche's Genentech unit. Altuzan is approved for use in Turkey — but not in the U.S.
The peace plan brokered by international envoy Kofi Annan and backed the United Nations has yet to curb the violence in Syria.
Reuters reports that even though a U.N. team of peacekeepers is scheduled to arrive in Damascus, today or tomorrow, opposition activists said government forces continued their attack. They said about 80 people have been killed since Tuesday.